Loading grant details…
Administrative Supplement for the HEROS Study Serology
| Funder | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES |
|---|---|
| Recipient Organization | Icahn School of Medicine At Mount Sinai |
| Country | United States |
| Start Date | Feb 11, 2021 |
| End Date | May 31, 2022 |
| Duration | 474 days |
| Number of Grantees | 2 |
| Roles | Principal Investigator; Co-Investigator |
| Data Source | NIH (US) |
| Grant ID | 10311727 |
Grant Description
The COVID-19 pandemic is the most important health challenge to the US population within a century.
Most epidemiological data have focused on cases that resulted in severe respiratory disease seen predominantly in adults.
Inadequate information regarding the infection burden in children is available, especially in the context of households that are prospectively monitored with repetitive testing. This information is critical to determine the silent and symptomatic infection rate in children. The NIAID-supported Human Epidemiology and Response to SARS- CoV-2 (HEROS) survey study is designed to fill this gap.
All Grantees
Icahn School of Medicine At Mount Sinai
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Related Grants
